You are here

JPMHC 2018

Three Interviews From the J.P. Morgan Healthcare Conference

Motley Fool

Mon, 01/15/18 - 06:37 pm

Arena Pharmaceuticals

Spark Therapeutics

Closing JPM18: Winners and losers, brighter days for neuroscience

Biopharma Dive

Sat, 01/13/18 - 10:58 pm

channel stuffing

Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms

TheStreet.com

Fri, 01/12/18 - 10:52 am

JPM18: Novavax investors cheer RSV vaccine update, then pull back

Biopharma Dive

Thu, 01/11/18 - 11:49 pm

Here's What Celgene's Management Just Said About Its Future

Motley Fool

Thu, 01/11/18 - 09:51 am

J&J chief’s pharma-tech vision is pretty, but it’s certainly not reality: experts

Fierce Pharma

Thu, 01/11/18 - 09:50 am

After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO

Fierce Pharma

Thu, 01/11/18 - 09:48 am

Bristol-Myers Squibb

Giovanni Caforio

Biotech CEOs unfazed by Brexit

Biopharma Dive

Thu, 01/11/18 - 09:47 am

Lilly CEO: With pharma friends in high places, it's 'time for action' to ease drug costs

Fierce Pharma

Wed, 01/10/18 - 06:58 pm

JPM18: Incyte and Syros to collaborate in cancer R&D

Biopharma Dive

Wed, 01/10/18 - 06:57 pm

Syros Pharmaceuticals

JPM18: GSK's Walmsley weighs in on Pfizer, gender diversity

Biopharma Dive

Wed, 01/10/18 - 06:53 pm

gender diversity

JPM18: bluebird set to file 3 drugs for approval by 2019

Biopharma Dive

Wed, 01/10/18 - 10:21 am

Sanofi and Regeneron's Dupixent launch is about to get a cash infusion

Fierce Pharma

Wed, 01/10/18 - 10:07 am

Drug pricing pressure isn't likely to get worse: Merck CEO

Fierce Pharma

Tue, 01/9/18 - 11:49 pm

Kenneth Frazier

JPMing while female: Women share their experiences at biopharma’s big gathering

Stat

Tue, 01/9/18 - 11:48 pm

women executives

sexual harassment

gender discrimination

5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce

Motley Fool

Tue, 01/9/18 - 10:58 pm

gene sequencing

Don't expect Restasis generics till at least next quarter, Allergan CEO says

Fierce Pharma

Tue, 01/9/18 - 10:52 pm

The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past

Motley Fool

Tue, 01/9/18 - 10:17 am

Johnson & Johnson Wants to Create a Crisis -- and That's Great for Investors

Motley Fool

Tue, 01/9/18 - 10:14 am

The Winners And Losers Of JP Morgan Monday

Forbes

Mon, 01/8/18 - 10:23 pm

Cellular Biomedicine

Alder Biopharmaceuticals

PTC Therapeutics

Axovant Sciences

Oxford Immunotec

Pages